Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 13, Number 1—January 2007

Research

Spread of Cryptococcus gattii in British Columbia, Canada, and Detection in the Pacific Northwest, USA

Laura MacDougall*Comments to Author , Sarah E. Kidd†, Eleni Galanis*, Sunny Mak*, Mira J. Leslie‡, Paul R. Cieslak§, James W. Kronstad†, Muhammad G. Morshed*, and Karen H. Bartlett†
Author affiliations: *British Columbia Centre for Disease Control, Vancouver, British Columbia, Canada; †University of British Columbia, Vancouver, British Columbia, Canada; ‡Washington State Department of Health, Shoreline, Washington, USA; §Oregon State Public Health, Portland, Oregon, USA;

Main Article

Figure 4

URA5–restriction fragment length polymorphism (RFLP) profiles for selected human, animal, and environmental Cryptococcus gattii isolates. A) URA5-RFLP to determine the molecular type using Hha I and Sau96 I endonucleases (14). B) URA5-RFLP to confirm molecular type and determine VGII subtype, using Hha I, Dde I, and BsrG I endonucleases.

Figure 4. URA5–restriction fragment length polymorphism (RFLP) profiles for selected human, animal, and environmental Cryptococcus gattii isolates. A) URA5-RFLP to determine the molecular type using Hha I and Sau96 I endonucleases (14). B) URA5-RFLP to confirm molecular type and determine VGII subtype, using Hha I, Dde I, and BsrG I endonucleases.

Main Article

TOP